Articles by Abby Proch

1. What's The Role Of HEOR For A Clinical Researcher? A Perspective From ISPOR 2026 6/1/2026

   On the heels of ISPOR 2026, discover what relevancy HEOR has in the world of clinical operations.

2. How Did You End Up In Clinical Research? 5/20/2026

   To commemorate Clinical Trials Day, we asked clinical researchers to share their story, answering, "How did you get into clinical research?"

3. What Sites, Sponsors, Vendors, And CROs Can All Agree On 4/17/2026

   Experts representing sponsors, sites, vendors, and CROS discussed at Life Sciences Future SW the pain points and the opportunities that lie ahead in clinical research.

4. The Latest On RBM Uptake? Tufts Says Most, But Not All, Pharma On Board 3/5/2026

   Tufts CSDD’s Beth Harper shares findings from the org's latest Impact Report and discusses how companies might better define risk, measure success, and understand central monitoring. 

5. Pick The Right PV Technology With Help From A Safety Data Management Expert 2/27/2026

   Otsuka's Head of U.S. GPV Safety Data Management Vikalp Khare shares how smart governance should inform pharmacovigilance (PV) technology choices.

6. Heard At SCOPE: Pharma Wants ROI For Patient Data Return, Diverse Enrollment 2/11/2026

   Twice I heard “ROI is the elephant in the room.” Two different panel discussions, two different tracks. 

7. Becoming A Backbone Therapy: Lessons Learned With Actuate Therapeutics 2/5/2026

   CEO Dan Schmitt discusses the pursuit of a backbone therapy and how Actuate's current and planned trials are structured to confirm that potential.

8. 3 Clinical Research Attorneys Talk 2026 Trends 1/23/2026

   Three life sciences legal experts share what they see happening in the year ahead — and what should remain firmly in the past. 

9. Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders 1/23/2026

   Digital protocols could reduce manual effort and enable rapid and more consistent downstream study execution, reporting, and submission processes. TransCelereate BioPharma's Rob DiCicco and Novartis' Bill Illis explain.

10. "Study Within A Study" Reveals Best Recruitment Strategies For Alzheimer's Trials 1/20/2026

    In this Q&A, Acumen Pharmaceuticals shares findings from its Alzheimer's recruitment study, highlighting what efforts proved the most fruitful.